
Lifeng Kang
@sydneylifeng
PhD, Associate Professor, Researcher, Runner.
ID: 360480151
https://www.kanglab.net 23-08-2011 08:25:23
206 Tweet
337 Followers
787 Following


We reviewed the recent progress on photoactivable liposomes for controlled drug release and advanced therapeutics.authors.elsevier.com/c/1i9Nx2Tz3-Eg0 인하대학교 USC University of Sydney Sydney Health Andrew McLachlan Centre for Drug Discovery Innovation Drug Delivery Australia Controlled Release Society #medicine #pharmacy #drug


Six years after filing, our patent (a microneedle device) is finally granted in US ( patents.google.com/patent/US11801… ) and licensed (nusmetics.com) University of Sydney NUS Sydney Nano Centre for Drug Discovery Innovation Drug Delivery Australia Controlled Release Society #drugs #medicine #healthcare #microneedle #Skin

We 3D printed human liver organoids to identify toxins causing liver cancer. sciencedirect.com/science/articl… #pharmaceuticals #analysis #livercancer #3dprinting #hydrogel #organoids #dna University of Sydney Sydney Health

We use modified cholesterol molecules and albumin to make nanoparticles to selectively impede the metabolic action of cancer cells, published in Nature Nanotechnology. nature.com/articles/s4156… #cancer #nanoparticles Nanjing University University of Sydney Controlled Release Society Drug Delivery Australia


We reviewed lipid and inorganic nanocarriers and assessed their potential for delivering drugs into/through skin. University of Sydney Sydney Health 华中科技大学 king saud university Macquarie University Nial Wheate Andrew McLachlan Drug Delivery Australia Controlled Release Society

We prepared a vancomycin laden hydrogel to prevent surgical site infection (SSI). sciencedirect.com/science/articl… University of Sydney Sydney Health NUS Temasek Polytechnic Technion Israel Edwin Tan Andrew McLachlan Controlled Release Society Drug Delivery Australia

Working with Shrike Zhang, we are now editing are a special issue on Pharmaceutical and Biological 3D Printing. sciencedirect.com/special-issue/… Harvard University Harvard Medical School University of Sydney Sydney Health Andrew McLachlan Y. Shrike Zhang

ADDR in press: Recent applications of three-dimensional bioprinting in drug discovery and development. By Lifeng Kang & coworkers Sydney Health Drug Delivery Australia #3Dbioprinting #DrugDiscovery doi.org/10.1016/j.addr…


We reviewed the potential use of 3D printers in hospital and compounding pharmacies. doi.org/10.1088/1758-5… #pharmacy #3dprint #medicine #hospital University of Sydney Sydney Health Andrew McLachlan Edwin Tan Triastek Inc.



ADDR 50 days' free access: Chaotic (bio)printing in the context of drug delivery systems. By Grissel Trujillo-de Santiago & coworkers Centro de Biotecnología FEMSA #bioprinting #TissueModel kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…


We developed a biosensor capable of real-time monitoring of both electrical and optical signals associated with key biomarkers, including NADH. pubs.acs.org/doi/10.1021/ac… #biosensing #biomarkers #nanowire Admission Office CPU University of Sydney Sydney Health Andrew McLachlan

We reviewed liquid biopsies as tools for predicting and monitoring the effectiveness of immune checkpoint inhibitors (ICIs) in cancer immunotherapy. authors.elsevier.com/c/1l2F82Tz46sPm #Immunology #Cancer #Biotech 인하대학교 University of Sydney Sydney Health Andrew McLachlan

🚨Drug Delivery Australia is coming back the 17-18th November! Keep an eye on Drug Delivery Australia and crsaustralia.org for more updates. We look forward to seeing you all soon! Controlled Release Society Vipul Agarwal Andrew Care Peter Wich – WichLab Lifeng Kang


We edit a thematic issue: "Integrating Complex Systems, Statistical Modeling, Machine Learning, and AI in Cancer Research and Survival Analysis." shorturl.at/WF27D We warmly invite your contribution. Florida Tech Sydney Health Andrew McLachlan #CancerResearch #complex
